Dyslipidemia Terminated Phase 3 Trials for Rosiglitazone (DB00412)

Also known as: Dyslipaemia / Dyslipidaemia / Dyslipidemias / Dyslipidaemias

IndicationStatusPhase
DBCOND0020718 (Dyslipidemia)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00361868Fenofibrate and Metformin Fixed Combination vs Rosiglitazone - FAME ROSITreatment